FJ Barrantes - Progress in lipid research, 2022 - Elsevier
The role of cholesterol in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other coronavirus-host cell interactions is currently being discussed in the context of two …
Although various pharmacologic agents are under active study [1], there are currently no effective and evidence-based antiviral drugs or drug combinations against severe acute …
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the coronavirus disease 2019 (COVID-19) has infected millions of individuals and has claimed …
A Vitiello, F Ferrara - Cardiovascular Toxicology, 2021 - Springer
Since the onset of the global COVID-19 pandemic, there has been much discussion about the advantages and disadvantages of ongoing chronic drug therapies in SARS-CoV-2 …
Inhibitors of 3-hydroxy-3methylgultaryl-coenzyme A reductase (statins) are one of the main groups of drugs used in preventing and treating cardiovascular diseases worldwide. They …
S Kunal, K Gupta, S Gupta - Heart & Lung, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread around the world like a wildfire in the past six …
E Kočar, T Režen, D Rozman - … et Biophysica Acta (BBA)-Molecular and …, 2021 - Elsevier
Cholesterol is being recognized as a molecule involved in regulating the entry of the SARS- CoV-2 virus into the host cell. However, the data about the possible role of cholesterol …
A Pawlos, M Niedzielski, P Gorzelak-Pabiś… - International Journal of …, 2021 - mdpi.com
The virus responsible for the current COVID-19 pandemic is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a new virus with high infectivity and moderate …
M Bifulco, P Gazzerro - Pharmacological Research, 2020 - ncbi.nlm.nih.gov
Taking into account the SARS-coronavirus 2 (SARS-CoV-2 also know as COVID-19) spreading and invasiveness in this critic period and the lack of therapeutic drugs and …